Award-Winning Journalist Anjalee Khemlani to Host Virtual Roundtable with Leading Medical Experts to Discuss Latest Developments in Treating Acute Agitation Related to Neuropsychiatric Conditions

On December 8, 2025, a timely virtual roundtable will convene at 10 a.m. EST, hosted by award-winning healthcare journalist Anjalee Khemlani. The event will feature leading medical experts discussing acute agitation associated with neuropsychiatric conditions like bipolar disorder and schizophrenia. Sponsored by BioXcel Therapeutics, this one-hour session aims to explore innovative treatment paradigms, particularly the promising aspect of self-administered treatments that can be utilized in home settings.

The roundtable is particularly relevant, given the staggering estimate of 57 to 77 million annual episodes of agitation in the U.S. alone, highlighting the pressing need for new approaches in managing these conditions outside of traditional healthcare settings such as emergency rooms and psychiatric facilities. Khemlani, known for her in-depth healthcare reporting at platforms like Yahoo Finance and NJBIZ, will guide the discussion, inviting insights from expert panelists, including Dr. Leslie Citrome, Dr. Marc A. Milano, and Dr. Leon Ravin. They will address the advantages and opportunities of at-home treatment options that could revolutionize patient care.

Participants in the audience will have the opportunity to engage directly with the panel during a designated Q&A session, facilitating an interactive discourse on the advancements in treatment strategies. Following the event, a recording will be available on the BioXcel Therapeutics website for further insights.

As a biopharmaceutical company utilizing artificial intelligence for drug development in neuroscience, BioXcel is at the forefront of transformative medicine, combining existing drug knowledge with machine learning to innovate therapeutic solutions. For additional details and pre-registration for the roundtable, interested individuals can visit the provided link.

In light of BioXcel Therapeutics' upcoming virtual roundtable hosted by renowned journalist Anjalee Khemlani, there are several compelling insights for investors and healthcare professionals to consider. The event scheduled for December 8 is an opportunity to gather critical information on the future of treating acute agitation associated with neuropsychiatric disorders, particularly in the wake of changing treatment paradigms toward home care.

As the healthcare landscape shifts, particularly with the burgeoning need for self-administered treatments, companies like BioXcel are uniquely positioned to capitalize on these trends. With an annual occurrence of 57 to 77 million agitation episodes in the U.S. alone, there is a substantial market for home treatment solutions that effectively address these events without necessitating emergency care.

The roundtable features influential experts such as Drs. Leslie Citrome, Marc Milano, and Leon Ravin. Their insights on self-administration technology could signal emerging market opportunities for pharmaceutical players focused on innovative treatment delivery systems. Investors should closely monitor BioXcel’s position and technology innovations stemming from their AI-driven approach in drug re-innovation.

Given the sustained interest from both clinicians and caregivers in accessible treatment options, this event is likely to attract significant attention and foster dialogue that could lead to collaborative innovations. Stakeholders and investors would benefit from engaging with the discussions, as they could provide actionable insights into the evolving landscape of psychiatric treatment, potentially shaping investment strategies in the future.

With current market trends favoring utilities that improve quality of care and patient autonomy, BioXcel therapeutics may be a noteworthy entity for investment consideration. Ensure to review the insights shared during the roundtable for a deeper understanding of industry dynamics and potential investment strategies.